Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Study: Pricing for more than 1,200 drugs rose higher than inflation

October 03, 2022 Reprints

Drugmakers raised the list prices of more than 1,200 treatments above the 8.5% rate of inflation from July 2021 to July 2022, according to a new report from the Department of Health and Human Services, Axios reports. The HHS report highlights the potential impact of the drug pricing provisions in the Inflation Reduction Act that President Biden signed into law in August, which requires drug companies to pay rebates to Medicare if prices rise beyond the rate of inflation.

Help

Study: Pricing for more than 1,200 drugs rose higher than inflation

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources